GRP
SNOA icon

Global Retirement Partners’s Sonoma Pharmaceuticals SNOA Stock Holding History

Global Retirement Partners’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.13K Buy
+2,548
New +$3.64K ﹤0.01% 3847
2025
Q4 		$2.81K Buy
772
+334
+76% +$1.23K ﹤0.01% 3622
2025
Q3 		$1.7K Buy
+438
New +$1.72K ﹤0.01% 3369

Other funds holding SNOA

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCWS
McKinley Carter Wealth Services Wheeling, West Virginia $1.94B AUM 20.7% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Global Retirement Partners's SNOA Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Sonoma Pharmaceuticals (SNOA) in Q2 2026: 2,548 shares worth $3.13K. The stake represents ﹤0.01% of the portfolio and ranks #3847 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in SNOA as recently as Q4 2025.

Global Retirement Partners first reported a position in SNOA in Q3 2025 and has held it in 3 quarters since. 14 funds tracked by Wall St. Rank hold SNOA as of Q2 2026.

  • Global Retirement Partners held 2,548 shares of Sonoma Pharmaceuticals worth $3.13K as of Q2 2026.
  • Sonoma Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Sonoma Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3847 holding.
  • Global Retirement Partners first reported a position in Sonoma Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.